Search Results 211-220 of 17149 for egfr

  1. The Barriers to Kidney Transplants in Patients with Chronic Kidney Disease - Mayo Clinic

    chronic kidney disease with eGFR < 20. Whether currently on dialysis or not. Excusion Criteria: Patients who had a previous kidney transplant. Patients who ...

  2. A Phase 2/3 Study On The Efficacy And Safety Of Mangaciclanol For ContrastEnhanced MRI Of CNS Or Body In Adult Patients - Mayo Clinic

    (Phase 3 only) Participant with an eGFR <30 mL/min/1.73m2 calculated using the CKD-EPI within 14 days prior to the first IMP administration. Participant ...

  3. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors - Mayo Clinic

    EGFR amplifications in the absence of EGFR-activating mutations; Cancers with exon 20 mutations; Previous treatment with erlotinib or any other EGFR inhibitor ...

  4. Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V - Mayo Clinic

    commencement of therapy with corticosteroids in combination with MMF/MPS. eGFR ≥ 30 ml/min/1.73 m2 Vaccination against Neisseria meningitidis and Streptococcus

  5. A Study to Evaluate the Veniti Vici™ Venous Stent System in Patients with a Chronic Iliofemoral Venous Outflow Obstruction - Mayo Clinic

    Has an estimated glomerular filtration rate (eGFR) <30 mL/min. In patients with diabetes mellitus, eGFR <45 mL/min. Has known hypersensitivity to nickel or ...

  6. Stage 4 (Metastatic) Colon Cancer Clinical Trials - Mayo Clinic Research

    ... EGFR containing regimens. The primary purpose of this study for Step 2: To assess the anti-tumour activity of MEN1611 in combination with cetuximab in ...

  7. Low Dose ColchicinE In PAtients With Peripheral Artery DiseasE To Address Residual Vascular Risk - Mayo Clinic

    eGFR \< 30 mL/min/1.73 m2 5. Cirrhosis or severe chronic liver disease 6. Woman who is pregnant, or breast-feeding or of child-bearing potential not ...

  8. A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease - Mayo Clinic

    eGFR ≥25 and ≤75 mL/min/1.73m2 (CKD-EPI Formula) at visit 1; Evidence of increased albuminuria 3 months or more before visit 1 and UACR ≥200 and ≤5000 mg ...

  9. Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects - Mayo Clinic

    - Estimated glomerular filtration rate (eGFR) < 80 mL/min/1.73 m2 at Screening. - Oral or parenteral antibiotics within 4 weeks prior to Screening, or ...

  10. Correlation of SOZO BIS Measures With CardioMEMS PA Pressure - Mayo Clinic

    Patient has estimated glomerular filtration rate (eGFR) < 20 ml/min/1.73m2 or end-stage renal disease requiring chronic dialysis. Patient has been diagnosed ...